These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29359367)

  • 1. Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.
    Benfodda M; Gazal S; Descamps V; Basset-Seguin N; Deschamps L; Thomas L; Lebbe C; Saiag P; Zanetti R; Sacchetto L; Chiorino G; Scatolini M; Grandchamp B; Bensussan A; Soufir N
    Genes Chromosomes Cancer; 2018 Jun; 57(6):294-303. PubMed ID: 29359367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
    Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
    Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline RAD51B truncating mutation in a family with cutaneous melanoma.
    Wadt KA; Aoude LG; Golmard L; Hansen TV; Sastre-Garau X; Hayward NK; Gerdes AM
    Fam Cancer; 2015 Jun; 14(2):337-40. PubMed ID: 25600502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
    Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
    PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma.
    Wadt K; Choi J; Chung JY; Kiilgaard J; Heegaard S; Drzewiecki KT; Trent JM; Hewitt SM; Hayward NK; Gerdes AM; Brown KM
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):815-8. PubMed ID: 22889334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene.
    Puig S; Ruiz A; Castel T; Volpini V; Malvehy J; Cardellach F; Lynch M; Mascaro JM; Estivill X
    Hum Genet; 1997 Dec; 101(3):359-64. PubMed ID: 9439668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
    Goldstein AM; Struewing JP; Chidambaram A; Fraser MC; Tucker MA
    J Natl Cancer Inst; 2000 Jun; 92(12):1006-10. PubMed ID: 10861313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
    Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
    Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of XPG rs17655G>C and XPF rs1799801T>C Polymorphisms with Susceptibility to Cutaneous Malignant Melanoma: Evidence from a Case-Control Study, Systematic Review and Meta-Analysis.
    Mohammadreza Niktabar S; Alireza Dastgheib S; Heiranizadeh N; Kargar S; Raee-Ezzabadi A; Jarahzadeh MH; Mohsen Miresmaeili S; Zare-Shehneh M; Neamatzadeh H
    Klin Onkol; 2020; 33(3):184-194. PubMed ID: 32683874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.
    Wei Q; Lee JE; Gershenwald JE; Ross MI; Mansfield PF; Strom SS; Wang LE; Guo Z; Qiao Y; Amos CI; Spitz MR; Duvic M
    J Natl Cancer Inst; 2003 Feb; 95(4):308-15. PubMed ID: 12591987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
    Ruiz A; Puig S; Malvehy J; Lázaro C; Lynch M; Gimenez-Arnau AM; Puig L; Sánchez-Conejo J; Estivill X; Castel T
    J Med Genet; 1999 Jun; 36(6):490-3. PubMed ID: 10874641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood DNA methylation, nevi number, and the risk of melanoma.
    Pergoli L; Favero C; Pfeiffer RM; Tarantini L; Calista D; Cavalleri T; Angelici L; Consonni D; Bertazzi PA; Pesatori AC; Landi MT; Bollati V
    Melanoma Res; 2014 Oct; 24(5):480-7. PubMed ID: 25026000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.
    Lubbe SJ; Escott-Price V; Brice A; Gasser T; Pittman AM; Bras J; Hardy J; Heutink P; Wood NM; Singleton AB; Grosset DG; Carroll CB; Law MH; Demenais F; Iles MM; ; Bishop DT; Newton-Bishop J; Williams NM; Morris HR;
    Neurobiol Aging; 2016 Dec; 48():222.e1-222.e7. PubMed ID: 27640074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
    Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
    BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the syntaxin 17 gene are not associated with human cutaneous malignant melanoma.
    Zhao ZZ; Duffy DL; Thomas SA; Martin NG; Hayward NK; Montgomery GW
    Melanoma Res; 2009 Apr; 19(2):80-6. PubMed ID: 19209086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
    Yang XR; Pfeiffer RM; Wheeler W; Yeager M; Chanock S; Tucker MA; Goldstein AM
    Int J Cancer; 2009 Dec; 125(12):2912-7. PubMed ID: 19626699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin.
    Kadouri L; Temper M; Grenader T; Abeliovich D; Hamburger T; Peretz T; Lotem M
    Fam Cancer; 2009; 8(1):29-32. PubMed ID: 18679827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
    Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.